0001571049-15-006091.txt : 20150731
0001571049-15-006091.hdr.sgml : 20150731
20150731210018
ACCESSION NUMBER: 0001571049-15-006091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150729
FILED AS OF DATE: 20150731
DATE AS OF CHANGE: 20150731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BFI Co., LLC
CENTRAL INDEX KEY: 0001601607
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 151020721
BUSINESS ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 2013297300
MAIL ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
4
1
t1501773_x1-bfi.xml
OWNERSHIP DOCUMENT
X0306
4
2015-07-29
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001601607
BFI Co., LLC
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666
0
0
1
0
Class A Common Stock
2015-07-29
4
C
0
18000
A
84000
D
Class A Common Stock
2015-07-29
4
S
0
6000
37.006
D
78000
D
Class A Common Stock
2015-07-30
4
S
0
6000
38.007
D
72000
D
Class A Common Stock
2015-07-31
4
S
0
8807
39.583
D
63193
D
Class B Common Stock
2015-07-29
4
C
0
18000
D
Class A Common Stock
18000
21247275
D
The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.38, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $39.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.74 to $40.02, inclusive.
/s/ Thomas G. Dagger, as Attorney-in-Fact for BFI Co., LLC
2015-07-31